With the slowdown in world economic growth, the Animal Stem Cell Therapy Industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Animal Stem Cell Therapy market size to maintain the average annual growth rate of 0.148698354997 from 8.0 million $ in 2014 to 16.0 million $ in 2018, Stratagem Market Insights analysts believe that in the next few years, Animal Stem Cell Therapy market size will be further expanded, we expect that by 2023, The market size of the Animal Stem Cell Therapy will reach 80.0 million $.
Grab Sample of this Report at: @
Stem cell therapy has changed the outlook of treatment as it has seen many groundbreaking advancements in the recent few years. The application of stem cell therapy has also expanded to animals now especially for cats and dogs. The regenerative medicine is very useful in the treatment of spinal cord and injuries associated with bone and ligaments, tendons, and joints. The animal stem cell therapy process includes three steps which cover the extraction of stem cell sample from animals, concentrate the stem cells, and transferring of stem cells into the injured site for treatment. Stem cell therapy in animal improve the quality of life of the animal and increase the life expectancy with no side-effects.
The rising prevalence of the disease in animals coupled with the growing need to increase the life expectancy of animals is predominantly fueling the market growth of animal stem cell therapy. Moreover, advancement in stem cell therapy for the animal is further anticipated to augment the market growth over the forecast period. For instance, in March 2019, Medrego, the producer of veterinary regenerative medicine solutions in Northern Europe has introduced its new Stem Cell Therapy product for dogs – CaniCell.
From the geographical perspective, North America is expected to gain significant growth over the forecast period and this is due to the increasing prevalence of animal disease and rising awareness regarding the advanced therapies in the region. According to the U.S. government watchdog, America’s swine and cattle populations are highly vulnerable to the deadly and highly contagious foot-and-mouth disease.
Get Exclusive Discount at: @
Key Developments:
- In October 2019, Gallant, an animal biotech company on a mission to help pets live healthier and happier lives, announced the launch of its first and only nationwide stem cell banking solution for dogs.
- In April 2019, Boehringer Ingelheim Animal Health has introduced Arti-Cell Forte in Europe for the reduction of mild to moderate recurrent lameness associated with non-septic joint inflammation in horses.
- In May 2018, Global Stem cell Technology (GST) NV, a front-runner in the field of veterinary stem cell therapy, announced that it has raised EUR 5 million of funding for the further development and commercial launch of its veterinary product portfolio with a focus on orthopedic injuries, such as tendinitis and arthrosis.
- In November 2016 U.S. STEM CELL, INC., a Florida corporation a provider of novel regenerative medicine solutions and physician-based stem cell therapies to human and animal patients, has announced an agreement with Kuwait-based High Rising Group to launch U. S. Stem Cell Middle East.
This Report covers the manufacturers’ data, including shipment, price, revenue, gross profit, interview record, business distribution, etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume, and value, as well as price data.
Besides, the report also covers segment data, including type segment, industry segment, channel segment, etc. cover different segment market sizes, both volume, and value. Also cover different industries client’s information, which is very important for the manufacturers. If you need more information,
Section 1: Definition
Section (2 3): Manufacturer Detail
⤍ Medivet Biologics LLC
⤍ VETSTEM BIOPHARMA
⤍ J-ARM
⤍ U.S. Stem Cell, Inc
⤍ VetCell Therapeutics
⤍ Celavet Inc.
⤍ Magellan Stem Cells
⤍ Kintaro Cells Power
⤍ Animal Stem Care
⤍ Animal Cell Therapies
⤍ Cell Therapy Sciences
⤍ Animacel
Section 4: Region Segmentation
⤍ North America Country (United States, Canada)
⤍ South America
⤍ Asia Country (China, Japan, India, Korea)
⤍ Europe Country (Germany, UK, France, Italy)
⤍ Other Country (Middle East, Africa, GCC)
Section (5 6 7): Type Segmentation
Product Type Segmentation ➟
⤍ Dogs
⤍ Horses
Industry Segmentation ➟
⤍ Veterinary Hospitals
⤍ Research Organizations
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2019-2026)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
Industry Forecast Research 